Level D· Scientific groundwork from lab and animal studiesAnimal StudyEurope PMCOpen access

Extract of Bombycis Feces suppressed 3T3-L1 adipogenesis resulting in the regulation of fatty acid-dependent energy consumption

Lee YK., Lyu JH., Shin UC., Muthamil S., Bae CH., Kim SW.

Animal Study on Chronic Inflammation, published in Sci Rep (2025) — summary generated from the PubMed abstract.

Open my reading list
Level D· Scientific groundwork from lab and animal studiesEvidence level of this study

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

  • Level A · Stronger Clinical Evidence
  • Level B · Emerging clinical evidence with positive signals
  • Level C · Early human research exploring benefits
  • Level D · Scientific groundwork from lab and animal studies
  • Emerging · Emerging topic under active research
Read the A–D evidence level guide

This page is generated from the PubMed record. The Thai description is an automated summary of bibliographic fields and the abstract, not a full translation, and is not medical advice.

Study type
Animal Study
Journal
Sci Rep (2025)
Reported sample size
—
Source database
Europe PMC
PMID
40830614
PMCID
PMC12365174
DOI
10.1038/s41598-025-14700-x

Abstract (original English)

In Oriental medicine, silkworms and their derivatives have been used for anti-inflammatory and diabetic purposes. Bombycis Feces exhibit anti-atopic effects and anti-proliferative activity; however, the role of BF extract (BFE) in adipogenesis and obesity and management remains underexplored. This study examined the effects of BFE on amino acid oxidation during adipocyte differentiation. An adipogenesis model was established using 3T3-L1 cells. Intracellular lipid accumulation was assessed via Oil Red O staining, while cytotoxicity was evaluated using a cell viability assay. The effects of BFE on gene and protein expression, lipolysis, real-time oxygen consumption rate, and substrate oxidation during adipocyte differentiation were analyzed. The involvement of the branched-chain amino acid (BCAA) catabolic pathway and leptin gene expression was also evaluated. BFE treatment significantly downregulated the expression level of key adipogenic transcription factors, including PPARγ and C/EBPα, as well as aP2 gene expression. Lipid accumulation was significantly reduced, accompanied by increased expression of Sirt1 and Sirt6, but not Sirt3, and a concurrent reduction in Parp1 expression. In addition to adipogenesis, the oxygen consumption rate and extracellular acidification rate were downregulated by BFE treatment in adipocytes. Conversely, BFE enhanced amino acid-dependent oxidatio

What this study does not prove

  • • This study does not prove SVF is an approved treatment or a replacement for standard care.
  • • This is preclinical work; animal or laboratory results cannot be applied to humans.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

How we grade evidence
3T3-L1 CellsAdipocytesFecesAnimalsMiceFatty AcidsCell DifferentiationCell SurvivalEnergy MetabolismLipolysis

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.

Related research